Comparison of non-linear and linear models for estimating haemoglobin adduct stability

References

• BERGMARK, E., BELEW, M. and OSTERMAN-GOLKAR, S. 1990, Separation and enrichment of alkylated globin chains as a means of improving the sensitivity of hemoglobin adduct measurements. Ada Chemica Scandinavica, 44, 630–635.
   PubMedGoogle Scholar
• CHEEVER, K. L., RICHARDS, D. E., WEIGEL, W W, BEGLEY, K. B., DEBORD, D. G., SWEARENGIN, T. E and SAVAGE, R. E., JR 1990, 4,4'-Methylene-bis(2-chloroaniline) (MOCA): comparison of macromolecular adduct formation after oral or dermal administration in the rat. Fundamental and Applied Toxicology, 14, 273–283.
   PubMedGoogle Scholar
• CHO, M., JEDRYCHOWSKI, R., HAMMOCK, B. and BUCKPITT, A. 1994, Reactive naphthalene metabolite binding to hemoglobin and albumin. Fundamental and Applied Toxicology, 22, 26–33.
   PubMedGoogle Scholar
• DEBORD, D. G., SWEARENGIN, T. E, CHEEVER, K. L., BOOTH-JONES, A. D. and WISSINGER, L. A. 1992, Binding characteristics of ortho-toluidine to rat hemoglobin and albumin. Archives of Toxicology, 66, 231–236.
   Google Scholar
• DERELANKO, M. J. 1987, Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfiuorophosphate ([3FI]DFP) method. Funda-mental and Applied Toxicology, 9,271–276.
   PubMedGoogle Scholar
• DROZ, P. O. and Wu, M. M. 1991, Biological monitoring strategies. In Exposure Assessment for Epidemiology and Hazard Control, S. M. Rappaport and T. J. Snyder, eds (Chelsea, Michigan: Lewis Publishers), pp. 251–270.
   Google Scholar
• EHRENBERG, L., HIESCHE, K. D., OSTERMAN-GOLKAR, S. and WENNEBERG, I. 1974, Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutation Research, 24, 83–103.
   Google Scholar
• FENNELL, T. R., SUMNER, S. C. and WALKER, V. E. 1992, A model for the formation and removal of hemoglobin adducts. Cancer Epidemiology, Biomarkers and Prevention, 1,213–219.
   PubMed Web of Science ®Google Scholar
• GALLANT, A. R. 1987, Nonlinear Statistical Models (New York: John Wiley & Sons, Inc.).
   Google Scholar
• GORELICK, N. J., HUTCHINS, D. A., TANNENBAUM, S. R. and WOGAN, G. N. 1989, Formation of DNA and hemoglobin adducts of fiuoranthene after single and multiple exposures. Carcinogenesis, 10, 1579–1587.
   PubMed Web of Science ®Google Scholar
• GRANATH, E, EHRENBERG, L. and TORNQVIST, M. 1992, Degree of alkylation of macromolecules in vivo from variable exposure. Mutation Research, 284, 297–306.
   PubMed Web of Science ®Google Scholar
• GREEN, L. C., SKIPPER, P. L., TURESKY, R. J., BRYANT, M. S. and TANNENBAUM, S. R. 1984, In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Research, 44, 4254A–259.
   Web of Science ®Google Scholar
• MACLURE, M., BRYANT, M. S., SKIPPER, P L. and TANNENBAUM, S. R. 1990, Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. Cancer Research, 50, 181–184.
   PubMed Web of Science ®Google Scholar
• OSTERMAN-GOLKAR, S., EHRENBERG, L., SEGERBACK, D. and HALLSTROM, I. 1976, Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutation Research, 34, 1–10.
   PubMed Web of Science ®Google Scholar
• OSTERMAN-GOLKAR, S., CHRISTAKOPOULOS, A., ZORCEC, V. and SVENSSON, K. 1995, Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts. Chemico-Biological Interactions, 95, 79–87.
   PubMed Web of Science ®Google Scholar
• OSTERMAN-GOLKAR, S., LICEA PEREZ, H., CSANADY, G. A., KESSLER, W. and FILSER, J. G. 1999, Methods for monitoring of propylene oxide exposure in Fischer 344 rats. Toxicology, 134, 1–8. RAPPAPORT, S. M. 1985, Smoothing of exposure variability at the receptor: implications for health standards. Annals of Occupational Hygiene, 29, 201–214.
   Google Scholar
• RAPPAPORT, S. M. 1991, Assessment of long-term exposures to toxic substances in air. Annals of Occupational Hygiene, 35, 61–121.
   PubMed Web of Science ®Google Scholar
• RAPPAPORT, S. M. and SPEAR, R. C. 1988, Physiological damping of exposure variability during brief periods. Annals of Occupational Hygiene, 32, 21–33.
   PubMed Web of Science ®Google Scholar
• SEGERBACK, D., CALLEMAN, C. J., EHRENBERG, L., LOFROTH, G. and OSTERMAN-GOLKAR, S. 1978, Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after-treatment of mice with methyl methanesulfonate. Mutation Research, 49, 71–82.
   Google Scholar
• SUN, J. D., DAHL, A. R., BOND, J. A., BIRNBAUM, L. S. and HENDERSON, R. E 1989, Characterization of hemoglobin adduct formation in mice and rats after administration of [HC] butadiene or [14C]isoprene. Toxicology and Applied Pharmacology, 100, 86–95.
   PubMed Web of Science ®Google Scholar
• TROESTER, M. A., LINDSTROM, A. B., KUPPER, L. L., WAIDYANATHA, S. and RAPPAPORT, S. M. 2000, Stability of hemoglobin and albumin adducts of benzene oxide and 1,4-benzoquinone after administration of benzene to F344 rats. Toxicological Sciences, 54, 88–94.
   PubMed Web of Science ®Google Scholar
• VIAU, C., MERCIER, M. and BLONDIN, O. 1993, Measurement of hemoglobin and albumin adducts of benzo(a)pyrenediolepoxide and their rate of elimination in the female Sprague-Dawley rat. Archives of Toxicology, 67, 468–472.
   PubMed Web of Science ®Google Scholar
• WAIDYANATHA, S., YEOWELL-O'CONNELL, K. and RAPPAPORT, S. M. 1998, A new essay for albumin and hemoglobin adducts of 1,2- and 1,4-benzoquinones. Chemico-Biological Interactions, 115, 117–139.
   Google Scholar